IP Verse

Supratek Pharma, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Supratek Pharma, Inc. opposed by its competitors

Patent:
EP2792369
Grant Date:
Apr 18, 2018
Title:
Bendamustine Cyclopolysaccharide Compositions
Oppositions:
1

Competitors of Supratek Pharma, Inc.

INTAS PHARMACEUTICALS LTD.

Want to track Supratek Pharma, Inc.?

Feel free to send us a message here and we will get back to you